Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly EBITDA Margin came in at 2.18% in Q2 2026, up 4868.0% YoY from 0.04% in Q2 2025, and up 508.53% on a QoQ basis from 0.53% in Q1 2026.
Fortrea Holdings (FTRE) EBITDA Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of EBITDA Margin data on file, last reported at 2.18% in Q2 2026.
- Quarterly EBITDA Margin rose 4868.0% year-over-year to 2.18% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.4% (up 3340.0% YoY) and the FY2025 annual result came in at 32.04%, down 2604.0% from the prior year.
- EBITDA Margin climbed to 2.18% in Q2 2026, from 0.53% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 9.04% in Q3 2022 to a low of 79.86% in Q1 2025.
- A 5-year average of 7.45% and a median of 1.23% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2025 — EBITDA Margin tumbled 7421 bps — and 2026, when it soared 7932 bps.
- Tracing FTRE's EBITDA Margin over 5 years: stood at 2.85% in 2022, then tumbled by 219 bps to 3.38% in 2023, then tumbled by 136 bps to 7.98% in 2024, then jumped by 74 bps to 2.06% in 2025, then soared by 206 bps to 2.18% in 2026.
- The last three EBITDA Margin figures came in at 2.18% (Q2 2026), 0.53% (Q1 2026), and 2.06% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,569,866.34% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 2.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.18% |
| Mar 31, 2026 | -0.53% |
| Dec 31, 2025 | -2.06% |
| Sep 30, 2025 | -1.23% |
| Jun 30, 2025 | -46.50% |
| Mar 31, 2025 | -79.86% |
| Dec 31, 2024 | -7.98% |
| Sep 30, 2024 | -2.67% |
| Jun 30, 2024 | -7.68% |
| Mar 31, 2024 | -5.65% |
| Dec 31, 2023 | -3.38% |
| Sep 30, 2023 | 1.44% |
| Jun 30, 2023 | 4.36% |
| Mar 31, 2023 | 2.03% |
| Dec 31, 2022 | 2.85% |
| Sep 30, 2022 | 9.04% |
| Jun 30, 2022 | 8.98% |